Disc Medicine Inc’s recent filing unveils that its 10% Owner AI DMI LLC unloaded Company’s shares for reported $59.87 million on Oct 22 ’25. In the deal valued at $80.47 per share,744,047 shares were sold. As a result of this transaction, AI DMI LLC now holds 2,814,379 shares worth roughly $238.35 million.
Then, OrbiMed Private Investments VI bought 482,308 shares, generating $43,378,782 in total proceeds.
Before that, OrbiMed Genesis Master Fund, L bought 186,541 shares. Disc Medicine Inc shares valued at $16,777,498 were divested by the Shareholder at a price of $89.94 per share.
A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating.
Price Performance Review of IRON
On Monday, Disc Medicine Inc [NASDAQ:IRON] saw its stock fall -1.77% to $84.69. Over the last five days, the stock has lost -5.53%. Disc Medicine Inc shares have risen nearly 85.72% since the year began. Nevertheless, the stocks have risen 33.58% over the past one year. While a 52-week high of $95.95 was reached on 10/17/25, a 52-week low of $30.82 was recorded on 04/09/25.
Levels Of Support And Resistance For IRON Stock
The 24-hour chart illustrates a support level at 82.89, which if violated will result in even more drops to 81.10. On the upside, there is a resistance level at 86.99. A further resistance level may holdings at 89.30.
How much short interest is there in Disc Medicine Inc?
A steep rise in short interest was recorded in Disc Medicine Inc stocks on 2025-10-15, growing by 0.46 million shares to a total of 2.69 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 2.24 million shares. There was a rise of 16.96%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 27, 2025 when TD Cowen began covering the stock and recommended ‘”a Buy”‘ rating.
